Germany's Merck KGaA (MRK.XE) said Tuesday it has entered into a definitive agreement to acquire the microbiology business of Biotest AG (BIO.XE), Germany.

MAIN FACTS:

-The business has approximately 290 employees and generated sales of approximately EUR50 million in 2010.

-This business comprises heipha Dr. Muller GmbH, located in Eppelheim, Germany, as well as the Hycon business located in Dreieich, the subsidiaries in France, Japan and in the USA as well as further activities and employees in several European countries.

-The agreement is subject to antitrust approvals in Germany and Austria.

-Closing of the transaction is expected in the second half of 2011.

 
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
Biotest (PK) (USOTC:BTTAY)
過去 株価チャート
から 5 2024 まで 6 2024 Biotest (PK)のチャートをもっと見るにはこちらをクリック
Biotest (PK) (USOTC:BTTAY)
過去 株価チャート
から 6 2023 まで 6 2024 Biotest (PK)のチャートをもっと見るにはこちらをクリック